165 related articles for article (PubMed ID: 37848412)
21. Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
Jabbar KS; Arike L; Verbeke CS; Sadik R; Hansson GC
J Clin Oncol; 2018 Feb; 36(4):367-375. PubMed ID: 29166170
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic Cystic Lesions: Diagnostic, Management and Indications for Operation. Part I.
Bauer F
Chirurgia (Bucur); 2017; 112(2):97-109. PubMed ID: 28463669
[TBL] [Abstract][Full Text] [Related]
23. Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.
Jabbar KS; Verbeke C; Hyltander AG; Sjövall H; Hansson GC; Sadik R
J Natl Cancer Inst; 2014 Feb; 106(2):djt439. PubMed ID: 24523528
[TBL] [Abstract][Full Text] [Related]
24. A novel distinguishing system for the diagnosis of malignant pancreatic cystic neoplasm.
Shen X; Lu D; Xu X; Wang J; Wu J; Yan S; Zheng SS
Eur J Radiol; 2013 Nov; 82(11):e648-54. PubMed ID: 23932638
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines.
van Huijgevoort NCM; Del Chiaro M; Wolfgang CL; van Hooft JE; Besselink MG
Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):676-689. PubMed ID: 31527862
[TBL] [Abstract][Full Text] [Related]
26. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic ability of artificial intelligence using deep learning analysis of cyst fluid in differentiating malignant from benign pancreatic cystic lesions.
Kurita Y; Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Koda H; Tajika M; Shimizu Y; Nakajima A; Kubota K; Niwa Y
Sci Rep; 2019 May; 9(1):6893. PubMed ID: 31053726
[TBL] [Abstract][Full Text] [Related]
28. Very high CEA level in a large pancreatic cyst: is it a surgical indication by itself?
Zanini N; Fornelli A; Fiscaletti M; Fabbri C; Lombardi R; Polifemo AM; Baccarini P; Masetti M; Jovine E
Pancreatology; 2012; 12(3):203-5. PubMed ID: 22687373
[TBL] [Abstract][Full Text] [Related]
29. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
Matthaei H; Wylie D; Lloyd MB; Dal Molin M; Kemppainen J; Mayo SC; Wolfgang CL; Schulick RD; Langfield L; Andruss BF; Adai AT; Hruban RH; Szafranska-Schwarzbach AE; Maitra A
Clin Cancer Res; 2012 Sep; 18(17):4713-24. PubMed ID: 22723372
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of Pancreatic Cystic Neoplasms.
Chhoda A; Schmidt J; Farrell JJ
Gastrointest Endosc Clin N Am; 2023 Jul; 33(3):613-640. PubMed ID: 37245939
[TBL] [Abstract][Full Text] [Related]
31. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic lymphoepithelial cysts express CEA and can contain mucous cells: potential pitfalls in the preoperative diagnosis.
Raval JS; Zeh HJ; Moser AJ; Lee KK; Sanders MK; Navina S; Kuan SF; Krasinskas AM
Mod Pathol; 2010 Nov; 23(11):1467-76. PubMed ID: 20802468
[TBL] [Abstract][Full Text] [Related]
33. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.
Brugge WR; Lewandrowski K; Lee-Lewandrowski E; Centeno BA; Szydlo T; Regan S; del Castillo CF; Warshaw AL
Gastroenterology; 2004 May; 126(5):1330-6. PubMed ID: 15131794
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management.
Leung KK; Ross WA; Evans D; Fleming J; Lin E; Tamm EP; Lee JH
Ann Surg Oncol; 2009 Oct; 16(10):2818-24. PubMed ID: 19536601
[TBL] [Abstract][Full Text] [Related]
37. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts.
Khalid A; Brugge W
Am J Gastroenterol; 2007 Oct; 102(10):2339-49. PubMed ID: 17764489
[TBL] [Abstract][Full Text] [Related]
38. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and long-term survival of resected pancreatic cystic neoplasms in Finland. The first nationwide retrospective cohort analysis.
Vaalavuo Y; Antila A; Ahola R; Siiki A; Vornanen M; Ukkonen M; Sand J; Laukkarinen J
Pancreatology; 2019 Apr; 19(3):456-461. PubMed ID: 30808537
[TBL] [Abstract][Full Text] [Related]
40. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.
Ryu JK; Matthaei H; Dal Molin M; Hong SM; Canto MI; Schulick RD; Wolfgang C; Goggins MG; Hruban RH; Cope L; Maitra A
Pancreatology; 2011; 11(3):343-50. PubMed ID: 21757972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
